BURLINGTON, Vt. -- Triosyn Corp., a developer of products aimed at protecting against microbial threats, has announced that tests conducted by Health Canadas national microbiology laboratory show that Triosyn T-1000 series respirators protect against Severe Acute Respiratory Syndrome (SARS). The third-party tests, which validate Triosyns extensive testing, demonstrate that Triosyns filtration technology eliminates SARS viral particles from the air passing through the facemask.
Health Canada, the Canadian federal bureau of health, conducted independent testing on the efficacy of Triosyns facemask filter to protect against SARS coronavirus, the viral agent responsible for SARS. The test involved blowing air contaminated with the SARS coronavirus through the facemask and analyzing the airstreams that passed through the facemask for the presence of viral particles. Tests were conducted at three different exposure periods: 15, 60 and 120 minutes.
Health Canadas test results show that no coronavirus particles were detected in the airstreams that passed through the Triosyn T-1000 series respirator during any of the three different exposure periods.
Health Canadas tests confirm that the T-1000 is the worlds first personal facemask that can provide protection against the potentially deadly airborne SARS virus, said Pierre Jean Messier, CEO of Triosyn Corp. Police forces in North America are currently using the T-1000 facemask and we are introducing it throughout the world.
SARS is a potentially deadly respiratory virus, which currently has no vaccine. More than 8,400 people in 29 countries have contracted SARS, and more than 900 people have died worldwide since the emergence of SARS in November 2002. The World Health Organization (WHO) states that the virus can be transmitted through the air, via coughing or sneezing, on tiny droplets of bodily fluids.
The Triosyn T-1000 respirator, a disposable personal facemask manufactured with an innovative antimicrobial technology to protect the filtration materials from microbial deterioration, is certified by the National Institute for Occupational Safety and Heath (NIOSH) as an N95 filtering facepiece respirator. It is also CE certified in Europe.
Source: Triosyn Corp.
Long COVID: Urgent Findings, Including Brain Alterations, Call for Renewed Public Health Focus
October 21st 2024New research highlights long COVID’s global impact, cognitive decline, and societal consequences, urging renewed focus on prevention, including vaccination, mask use, and better air quality.
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety
NP and PA-Led Practices: A Possible Remedy for Health Care Worker Burnout
October 8th 2024Nurse practitioner (NP) and Physician Assistant (PA)-led practices offer autonomy, flexible schedules, and smaller patient loads, which could help mitigate burnout while reducing pressure on traditional healthcare systems and improving infection prevention.
Barrier Against Infection: Importance and Challenges of Isolation Room Cleaning in Hospitals
October 4th 2024Isolation rooms are essential for infection control in health care, relying on specialized design, advanced cleaning protocols, and technology to prevent cross-contamination and safeguard patient safety.